Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis McCarty

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
Frontiers in Psychiatry|August 28, 2020
Substance Use Disorders and COVID-19: Multi-Faceted Problems Which Require Multi-Pronged SolutionsWossenseged Birhane Jemberie, Jennifer Stewart Williams, Malin Eriksson, et al.
Drug and Alcohol Dependence|September 19, 2007
Treatment programs in the National Drug Abuse Treatment Clinical Trials NetworkDennis McCarty, Bret Fuller, Lee Ann Kaskutas, et al.
Addiction Science & Clinical Practice|April 10, 2018
Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staffJennifer McNeely, Pritika C Kumar, Traci Rieckmann, et al.
Journal of Substance Abuse Treatment|March 24, 2010
From research to the real world: buprenorphine in the decade of the Clinical Trials NetworkWalter Ling, Petra Jacobs, Maureen Hillhouse, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2011
Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphineP Todd Korthuis, David A Fiellin, Rongwei Fu, et al.
Addiction (Abingdon, England)|January 7, 2017
Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trialPhilip T Korthuis, Paula J Lum, Pamela Vergara-Rodriguez, et al.
The Journal of Pain|October 22, 2017
Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and NonusersRichard A Deyo, Sara E Hallvik, Christi Hildebran, et al.
Journal of Psychopharmacology (Oxford, England)|June 18, 2024
Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi studyPhilip Todd Korthuis, Kim Hoffman, Adrianne R Wilson-Poe, et al.
Psychiatric Services (Washington, D.C.)|February 9, 2007
Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefsDennis McCarty, Bret E Fuller, Cynthia Arfken, et al.
Journal of Substance Abuse Treatment|April 6, 2004
Self-help organizations for alcohol and drug problems: toward evidence-based practice and policyKeith Humphreys, Stephen Wing, Dennis McCarty, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Frontiers in Psychiatry|August 28, 2020
Substance Use Disorders and COVID-19: Multi-Faceted Problems Which Require Multi-Pronged SolutionsWossenseged Birhane Jemberie, Jennifer Stewart Williams, Malin Eriksson, et al.
Drug and Alcohol Dependence|September 19, 2007
Treatment programs in the National Drug Abuse Treatment Clinical Trials NetworkDennis McCarty, Bret Fuller, Lee Ann Kaskutas, et al.
Addiction Science & Clinical Practice|April 10, 2018
Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staffJennifer McNeely, Pritika C Kumar, Traci Rieckmann, et al.
Journal of Substance Abuse Treatment|March 24, 2010
From research to the real world: buprenorphine in the decade of the Clinical Trials NetworkWalter Ling, Petra Jacobs, Maureen Hillhouse, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2011
Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphineP Todd Korthuis, David A Fiellin, Rongwei Fu, et al.
Addiction (Abingdon, England)|January 7, 2017
Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trialPhilip T Korthuis, Paula J Lum, Pamela Vergara-Rodriguez, et al.
The Journal of Pain|October 22, 2017
Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and NonusersRichard A Deyo, Sara E Hallvik, Christi Hildebran, et al.
Journal of Psychopharmacology (Oxford, England)|June 18, 2024
Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi studyPhilip Todd Korthuis, Kim Hoffman, Adrianne R Wilson-Poe, et al.
Psychiatric Services (Washington, D.C.)|February 9, 2007
Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefsDennis McCarty, Bret E Fuller, Cynthia Arfken, et al.
Journal of Substance Abuse Treatment|April 6, 2004
Self-help organizations for alcohol and drug problems: toward evidence-based practice and policyKeith Humphreys, Stephen Wing, Dennis McCarty, et al.
Pageof 18